Excellent news, animal trials starting and to be finished early 2019.
"“The further we get down the road, the more viable the project becomes and the greater our chances are of securing a commercial partnership to bring it to market.... "
This strategy is much more conducive to shareholder value than the go it alone approach the old board followed with cardiocel
- Forums
- ASX - By Stock
- Ann: TAVR project progresses to animal trials
Excellent news, animal trials starting and to be finished early...
-
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$15.70 |
Change
-1.350(7.92%) |
Mkt cap ! $301.7M |
Open | High | Low | Value | Volume |
$16.50 | $16.50 | $15.52 | $571.1K | 35.69K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13 | $15.58 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.00 | 775 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 13 | 15.580 |
2 | 320 | 15.560 |
1 | 2496 | 15.550 |
2 | 558 | 15.530 |
3 | 765 | 15.520 |
Price($) | Vol. | No. |
---|---|---|
16.000 | 775 | 2 |
16.200 | 500 | 1 |
16.500 | 63 | 1 |
17.100 | 900 | 1 |
17.500 | 511 | 2 |
Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online